According to a new study, tumor necrosis factor (TNF) inhibitors and the antimalarial medication hydroxychloroquine used by many patients with rheumatoid arthritis and psoriasis may help reduce these patients' risk of developing diabetes. In fact, researchers found that taking TNF inhibitors decreased users' diabetes risk by 38 percent, while hydroxychloroquine dropped diabetes risk by 46 percent.
Read moreResearchers at the University of British Columbia and Arthritis Research Center of Canada, Vancouver, recently completed a study that has... Read more »
Studies have shown that people with RA are at greater risk of heart disease and cardiovascular events the longer they have RA. Women with... Read more »
Many people with RA develop osteoporosis. Studies have also shown that people with RA have an increased risk of hip fractures. A new... Read more »
May is Arthritis Awareness Month and I want to discuss the connection between rheumatoid arthritis and heart disease. If you live with... Read more »
Although I’ve had RA for most of my 31 years, until I read the Australian study this week, I never knew that people with RA have a higher... Read more »
A review of previous studies has found a link between the use of tumor necrosis factor (TNF) inhibitors such as Remicade (infliximab), Enbrel... Read more »
Results from a new study published in the Annals of the Rheumatic Diseases suggest that routine adult vaccinations, including those for the flu, do... Read more »
According to new study, people who are obese at age 18 have a higher risk of developing psoriatic arthritis than people who are normal weight at this... Read more »
Researchers at Georgetown University say that post-menopausal women who drink tea have a higher risk of developing rheumatoid arthritis (RA) than... Read more »
Scientists at Leiden University in the Netherlands have found that drinking alcohol reduces people's risk of developing rheumatoid arthritis,... Read more »